• LAST PRICE
    7.7000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    7.6500/ 2
  • Ask / Lots
    7.9000/ 2
  • Open / Previous Close
    0.0000 / 7.7000
  • Day Range
    ---
  • 52 Week Range
    Low 6.9700
    High 12.5900
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 7.81
TimeVolumeCMPS
09:32 ET59157.9
09:34 ET61228.015
09:36 ET5628.0253
09:38 ET24128.02
09:39 ET14247.99
09:41 ET3007.98
09:43 ET5467.98
09:48 ET5238.02
09:50 ET14477.94
09:52 ET3738.04
09:54 ET1008.035
09:56 ET4008
09:57 ET4278.0122
10:01 ET9007.935
10:06 ET4007.92
10:08 ET4007.92
10:12 ET14407.93
10:14 ET19217.88
10:17 ET4017.85
10:24 ET10007.94
10:26 ET8237.88
10:28 ET11877.86
10:30 ET1027.8604
10:32 ET8427.89
10:35 ET9007.89
10:37 ET2007.885
10:39 ET17357.83
10:42 ET9207.8582
10:44 ET3027.8306
10:46 ET16287.92
10:48 ET2007.93
10:50 ET7727.9
10:51 ET4007.89
10:53 ET2007.9
10:57 ET2007.92
11:00 ET9857.918
11:04 ET9007.91
11:06 ET10637.88
11:08 ET1007.8875
11:11 ET29517.8701
11:15 ET2007.88
11:18 ET5007.8874
11:24 ET10017.885
11:26 ET4907.87
11:29 ET1007.88
11:31 ET8007.87
11:36 ET3007.87
11:38 ET10117.875
11:42 ET7507.86
11:44 ET2507.8675
11:45 ET5007.85
11:47 ET3907.8492
11:49 ET15007.87
11:51 ET69357.89
11:58 ET2907.88
12:00 ET19797.85
12:02 ET540867.7738
12:03 ET63687.77
12:05 ET3007.72
12:09 ET8347.74
12:12 ET4007.7303
12:14 ET80317.71
12:16 ET39997.7198
12:18 ET14007.72
12:20 ET73427.72
12:21 ET16297.71
12:23 ET18377.71
12:25 ET12007.7001
12:30 ET103727.72
12:34 ET1007.73
12:36 ET28217.74
12:38 ET7587.72
12:39 ET3757.7129
12:41 ET1007.725
12:43 ET26757.7343
12:45 ET1007.725
12:48 ET25227.7352
12:50 ET8007.77
12:52 ET9347.76
12:54 ET8867.76
12:56 ET2007.75
12:57 ET1007.75
12:59 ET20447.75
01:01 ET5007.77
01:03 ET8237.78
01:06 ET10167.78
01:08 ET2007.78
01:10 ET8207.79
01:12 ET14257.82
01:14 ET5467.8
01:15 ET9057.78
01:17 ET8007.77
01:19 ET1007.765
01:24 ET19127.73
01:26 ET6227.735
01:28 ET4007.735
01:30 ET6007.735
01:32 ET9687.75
01:33 ET2177.77
01:35 ET36287.7933
01:37 ET3007.79
01:39 ET19157.79
01:42 ET5007.73
01:44 ET6007.7329
01:51 ET31197.765
01:55 ET22307.785
01:57 ET3007.78
02:00 ET3887.78
02:02 ET3147.79
02:04 ET1007.785
02:06 ET13967.79
02:08 ET5007.78
02:09 ET17137.785
02:11 ET5007.76
02:13 ET1007.765
02:15 ET2257.765
02:18 ET1007.78
02:20 ET6177.775
02:22 ET1007.78
02:24 ET5007.78
02:31 ET27127.83
02:33 ET3057.83
02:36 ET19697.84
02:38 ET2007.845
02:42 ET1007.83
02:44 ET2007.84
02:45 ET1007.845
02:47 ET14507.8599
02:49 ET13007.81
02:51 ET1007.81
02:54 ET1507.8134
02:56 ET3837.79
02:58 ET2007.8
03:00 ET1007.8
03:02 ET10837.8
03:05 ET19747.8
03:07 ET26017.8199
03:09 ET6007.8175
03:12 ET13757.8
03:14 ET1007.8
03:16 ET4007.7968
03:21 ET6007.78
03:23 ET11007.79
03:25 ET21007.81
03:27 ET1007.8
03:30 ET3007.78
03:34 ET7007.78
03:36 ET3737.77
03:38 ET1007.77
03:39 ET12007.77
03:41 ET47807.78
03:43 ET15967.79
03:45 ET5007.7893
03:48 ET7007.785
03:50 ET8347.775
03:52 ET54487.75
03:54 ET10957.73
03:56 ET112037.71
03:57 ET67897.7
03:59 ET602227.7
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCMPS
Compass Pathways PLC
352.5M
-3.3x
---
United StatesAURA
Aura Biosciences Inc
352.6M
-4.6x
---
United StatesORIC
Oric Pharmaceuticals Inc
350.6M
-2.9x
---
United StatesAPLM
Apollomics Inc
347.2M
-76.9x
---
United StatesALDX
Aldeyra Therapeutics Inc
358.0M
-6.9x
---
United StatesSPRY
ARS Pharmaceuticals Inc
347.9M
-10.6x
---
As of 2023-09-28

Company Information

COMPASS Pathways plc is a United Kingdom-based mental healthcare company. The Company is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression (TRD). The Company has developed COMP360, which is a psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin. The Company's COMP360 has completed a Phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America. This trial assessed the safety and efficacy of COMP360 psilocybin therapy in three doses: 1mg, 10mg, 25mg. The Company is also running a Phase II clinical trial of COMP360 psilocybin therapy for anorexia nervosa and post-traumatic stress disorder (PTSD). The Company is also developing its investigational COMP360 psilocybin therapy for the treatment of a range of mental health conditions, with an initial focus on TRD.

Contact Information

Headquarters
3Rd Floor, 1 Ashley RoadALTRINCHAM, United Kingdom WA14 2DT
Phone
---
Fax
---

Executives

Executive Chairman of the Board
George Goldsmith
Chief Executive Officer, Executive Director
Kabir Nath
Chief Financial Officer
Michael Falvey
General Counsel, Chief Legal Officer
Matthew Owens
Chief Medical Officer
Guy Goodwin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$352.5M
Revenue (TTM)
$0.00
Shares Outstanding
45.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.35
Book Value
$4.25
P/E Ratio
-3.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.